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Abstract
A systematic literature review was conducted to describe the epidemiology of dengue dis-
ease in Colombia. Searches of published literature in epidemiological studies of dengue dis-
ease encompassing the terms “dengue”, “epidemiology,” and “Colombia” were conducted.
Studies in English or Spanish published between 1 January 2000 and 23 February 2012
were included. The searches identified 225 relevant citations, 30 of which fulfilled the inclu-
sion criteria defined in the review protocol. The epidemiology of dengue disease in Colom-
bia was characterized by a stable “baseline” annual number of dengue fever cases, with
major outbreaks in 2001–2003 and 2010. The geographical spread of dengue disease
cases showed a steady increase, with most of the country affected by the 2010 outbreak.
The majority of dengue disease recorded during the review period was among those<15
years of age. Gaps identified in epidemiological knowledge regarding dengue disease in
Colombia may provide several avenues for future research, namely studies of asymptomat-
ic dengue virus infection, primary versus secondary infections, and under-reporting of the
disease. Improved understanding of the factors that determine disease expression and en-
able improvement in disease control and management is also important.
Author Summary
Dengue disease is caused by one of four serologically related, but antigenically distinct
dengue virus serotypes (DENV-1, -2, -3 or -4). It is the most prevalent arthropod-borne
viral disease, with a global distribution. Resource-poor countries are particularly vulnera-
ble to transmission of dengue disease and it is present throughout the Americas. Colombia
is one of the countries in the Americas most affected by epidemics of dengue disease,
which is a significant public health concern. We conducted this systematic literature re-
view to consolidate knowledge regarding the epidemiology of dengue disease in Colombia
using well-defined methods to search and identify relevant research, according to prede-
termined inclusion criteria. The findings reveal that despite vector control measures and
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003499 March 19, 2015 1 / 16
OPEN ACCESS
Citation: Villar LA, Rojas DP, Besada-Lombana S,
Sarti E (2015) Epidemiological Trends of Dengue
Disease in Colombia (2000-2011): A Systematic
Review. PLoS Negl Trop Dis 9(3): e0003499.
doi:10.1371/journal.pntd.0003499
Editor: Olaf Horstick, University of Heidelberg,
GERMANY
Received: February 12, 2014
Accepted: December 27, 2014
Published: March 19, 2015
Copyright: © 2015 Villar et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Funding: Sanofi Pasteur sponsored this survey and
analysis. The Literature Review Group (including
members of Sanofi Pasteur) were responsible for the
conception of the literature analysis, development of
the protocol, data collection, analysis and
interpretation of data, provision of critical comments,
writing the paper and approving the final version to be
published.
Competing Interests: LAV and DPR declare that
they received payments from Sanofi Pasteur in
respect of their work on this review. SBL and ES are
employed by Sanofi Pasteur. This does not alter our
adherence to all PLOS policies on sharing data and
constant improvement in diagnosis and clinical management of dengue disease cases by
health services, there has been no success in the effective control of the disease. This sys-
tematic review identifies important epidemiological characteristics of dengue disease in
Colombia, as well as identifying several avenues for future research.
Introduction
Dengue disease is the most prevalent arthropod-borne viral disease in humans and is caused by
any one of four serologically related, but antigenically distinct dengue virus serotypes (DENV-
1, -2, -3 or -4). The primary vector for viral transmission is the Aedes aegypti (Linnaeus) mos-
quito. Dengue disease is a rapidly increasing public health priority with a global distribution.
Resource-poor countries are particularly vulnerable to transmission of dengue disease [1], and
it is present in urban and suburban areas in the Americas, eastern Mediterranean, western Pa-
cific, South-East Asia and mainly rural areas in Africa [2]. Since 1997, symptomatic dengue dis-
ease has been categorized by the World Health Organization (WHO) as: undifferentiated fever,
dengue fever (DF) and dengue haemorrhagic fever (DHF) [3]. DHF was further classified into
four severity grades, with grades III and IV being defined as dengue shock syndrome (DSS).
However, a new classification was proposed by the WHO in 2009 based on levels of severity:
non-severe dengue disease with or without warning signs, and severe dengue disease, which en-
compasses DHF and DSS [4].
The WHO estimates that more than 50 million dengue virus infections and 20,000 dengue
disease-related deaths occur annually worldwide [2,5]. A recent disease distribution model
using a boosted regression tree framework estimated there to be 390 million dengue disease in-
fections in 2010, of which 96 million are clinically apparent [1]. In 2010, the countries of the
Americas notified in excess of 1.6 million cases of clinical dengue disease [6]. In Colombia, Ae.
aegypti infestation is widespread and dengue disease is endemic throughout most of the coun-
try. Approximately 23 million individuals are considered to be at-risk areas for dengue disease,
[7] however, recent reports of dengue disease and Ae. aegypti at altitudes>1800 metres [8] sug-
gest more people are at-risk.
Colombia has about 46 million inhabitants. Its land area is 1,141,748 km2, and three
branches of the Andean mountain range dominate its topography [6]. The country can be di-
vided into six geographical regions (Costa Atlantica, Costa Pacifica, Centro Oriente, Centro
Occidente, Orinoquia and Amazonia; S1 Fig.), each with distinguishing geographical, climatic
and environmental conditions (e.g., altitude, temperature, relative humidity and rainfall char-
acteristics). These regions also have some distinct demographic, socio-economic, political and
cultural features. Colombia comprises 32 administrative states called departments that vary
considerably in geographical area and size of population. In addition, 10 cities have been desig-
nated districts, including Bogotá, Barranquilla, Cartagena and Santa Marta.
Historically, Colombia is one of the countries in the Americas most affected by epidemics of
dengue disease [9,10], first recognized as a significant public-health target in the 1950s [11]. In
the 1980s, the Colombian National Epidemiological Surveillance System (SIVIGILA) estimated
dengue disease incidence was 65.6 per 100,000 population, with no reported severe disease or
death [7, 12]. Although the number of annual DF cases ranged from 6,776 to 17,510 during the
1980s [13], there was a clear increase over the decade which continued through the 1990s, with
large outbreaks documented in 1990, 1993, and 1998. [7]. The first case of DHF in Colombia
was officially notified in December 1989 from the village of Puerto Berrio (Antioquia depart-
ment) [10,14]. Between 1992 and 1996, more than 1,000 cases of DHF were reported and the
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frequency of fatal infections increased rapidly [15]. DENV-1 and DENV-2 were the most fre-
quently isolated serotypes in the 1980s and 1990s [12]. DENV-3 is generally believed to have
been absent from most of Colombia throughout the 1980s and 1990s [12, 16] re-emerging dur-
ing the 2002 outbreak [7, 17]. DENV-4 emerged in the early 1980s [12], and cases of DENV-
4-related DF have been reported every year since [18].
Surveillance system
It is mandatory to notify cases of dengue disease to SIVIGILA. Probable and confirmed cases
are reported weekly, and cases of serious dengue disease and mortality due to dengue disease
are notified immediately. Not all cases of dengue disease are laboratory-confirmed, although all
deaths due to dengue disease must be confirmed [19]. The sentinel surveillance system that
began in 2000 comprises sentinel institutions that routinely test five patients each week to
monitor circulating DENV serotypes. In the case of an outbreak, serological samples are taken
from 5% of cases of DF and all cases of serious dengue disease [19, 20]. In 2006, the surveillance
system for dengue disease in Colombia began to transition from collective to individual notifi-
cation. Both systems were used until 2008, after which the collective notification system was no
longer used. Discrepancies between local and national data sources may have arisen during the
transition period. The newer system generates more data, contributing to an enhanced knowl-
edge of dengue disease in Colombia. Since 2006, the Instituto Nacional de Salud has provided
regular disease updates through weekly bulletins and annual reports detailing national and re-
gional incidence information and annual data for dengue-related deaths. Case definitions of
dengue disease used in Colombia were changed in January 2010, as the newWHO definitions
of dengue disease were adopted [7].
Our systematic literature review describes the epidemiology of dengue disease in Colombia
between 1 January 2000 and 23 February 2012 in the context of national and regional (state
and district) trends. Incidence (by age and sex), seroprevalence and serotype distribution, and
other relevant epidemiological data are described. We also identify gaps in epidemiological
knowledge, and aim to provide a basis for defining research priorities for epidemiological stud-
ies of the disease and inform evidence-based policies in dengue disease prevention.
Materials and Methods
A Literature Review Group, comprised of epidemiology and dengue specialists, developed a
protocol based on previous literature surveys and analyses [21]. The protocol reflects the pre-
ferred reporting items of systematic literature reviews and meta-analyses (PRISMA) guidelines
[22] and details well-defined methods to search, identify and select relevant research, and pre-
determined inclusion criteria to guide study selection. The review protocol was registered on
PROSPERO, an international database of prospectively registered systematic reviews in health
and social care managed by the Centre for Reviews and Dissemination, University of York on
18 May 2012 (CRD42012002294): http://www.crd.york.ac.uk/PROSPERO/display_record.asp?
ID=CRD42012002294/. Papers, theses, dissertations, reports, statistical tables, official web sites
and grey materials (e.g., lay publications) were identified using an inclusive search strategy. A
heterogeneous group of articles with respect to data selection and classification of cases was an-
ticipated. As these would not be methodologically comparable, a meta-analysis was
not planned.
Search strategy and selection criteria
Searches for epidemiological data relating to dengue disease in Colombia were conducted in a
broad range of online sources (S1 Table) between 9 February 2012 and 23 February 2012.
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Specific search strategies for each electronic database were described with reference to the ex-
panded Medical Subject Headings thesaurus, encompassing the terms ‘dengue’, ‘epidemiology’
and ‘Colombia’. To help increase sensitivity and specificity, combinations of different search
strings were used for each electronic database.
Sources were included or excluded according to the criteria defined by the Literature Review
Group, which also guided the search and selection process described below, reaching consensus
via teleconferences. The criteria allowed for the inclusion of sources containing information re-
lated to general epidemiological indicators of dengue disease (incidence and seroprevalence);
intensity of dengue epidemics (frequency of hospitalization and severity of attack), populations
at increased risk of dengue disease, dengue serotype information, geography of dengue disease
and dengue surveillance systems. To reduce selection bias, studies published in English or
Spanish between 1 January 2000 and 23 February 2012 were included. This systematic review
utilised a protocol common to other reviews in this collection. Within that protocol it was esti-
mated that at least one decade of data would be necessary to provide an accurate image of re-
cent evolution of epidemiology and to observe serotype distribution over time and through
several epidemics and to limit any bias that might be introduced by changes in surveillance
practices over time; 1 January 2000 was selected as the lower end of the date range for this sys-
tematic review due to the sentinel surveillance system in Colombia also began in 2000 and be-
cause a summary country surveillance data was presented into the introduction The 23
February 2012 cut-off date reflects when the searches for this systematic review began. For da-
tabases that did not allow language and/or date limitations, references not meeting these crite-
ria were deleted manually at the first review stage. No limits by sex, age and ethnicity of study
participants or by study type were imposed, although single-case reports and studies that only
reported data for the period before 1 January 2000 were excluded. To reduce repetition of pub-
lished data repeated in meta-analyses or review publications, these duplicate data sets were ex-
cluded, unless reporting different outcome measures. Unpublished reports were included if
they were identified in one of the sources listed in S1 Table.
Data from other sources were included to complement articles selected in the primary sys-
tematic literature review: online reports and guidelines published by relevant organizations; pa-
pers and posters from infectious disease, tropical medicine or paediatric conferences; and grey
literature were identified through general internet searches (e.g. Google and Yahoo; limited to
the first 50 search results). Publications not identified by the approved search strategy and un-
published data sources meeting the inclusion criteria were included if recommended by mem-
bers of the Literature Review Group.
Following removal of duplicate citations, the Literature Review Group evaluated the list of
titles and abstracts, and selected articles considered potentially relevant. A second review was
undertaken on the full texts of these documents to select the final list of relevant articles. The
Literature Review Group ensured each study complied with the search inclusion and exclusion
criteria. Articles and other data sources were not excluded or formally ranked on the basis of
the quality of evidence. Although we recognize that assessment of study quality can potentially
add value to a systematic literature review, the consensus of the Literature Review Group was
that, in this instance, quality assessment would not add value given the expected high propor-
tion of surveillance data among the available data sources and the nature of surveillance data
(passive reporting of clinically suspected dengue disease). We therefore retained all available
data sources that met our criteria.
The data extraction instrument developed and used for a systematic literature review con-
ducted for Brazil [21] was used to collate and summarize the selected data sources in the form
of a series of Excel (Microsoft Corp., Redmond, WA) spreadsheets. Data were extracted into
the spreadsheets according to the following categories for descriptive review: incidence, age,
Systematic Literature Review of Dengue Epidemiology in Colombia
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003499 March 19, 2015 4 / 16
sex and serotype distribution, serotype data, seroepidemiology or seasonality and environmen-
tal factors, by national or regional groups. Data from literature reviews of previously published
peer-reviewed studies and pre-2000 data published within the search period were not extracted.
All members of the Literature Review Group had the opportunity to review and analyse the
original data sources and extraction tables. No attempt was made to contact researchers for
additional information.
Results
Searches identified 225 relevant citations, following the initial removal of duplicates and papers
not matching the study criteria 63 papers were evaluated. Of these 33 were excluded after de-
tailed review of the publication because on further examination data collection occurred out-
side the search criteria date range, they contained little epidemiological data relevant to the
study objectives or because they provided similar but less extensive data to that provided by
sources already included and thus provided insufficient information to be included in the re-
view. Some studies were excluded for more than one of these reasons. Consequently, 30 den-
gue-related sources were included (Fig. 1, S2 Table), of which, 14 and 16 sources were
published in English and Spanish, respectively. There were 18 journal articles and three confer-
ence presentations/abstracts. The majority of these publications (n = 8) provided analysis of
national surveillance data, providing dengue case counts, with some characterization by disease
severity, geographic region, and serotype. Six were cross-sectional studies usually limited to
specific geographic regions. Only two prospective studies were identified, four studies were
phylogenetic studies and one was a disease awareness survey. The remaining 9 sources were
recommended and accessed by members of the LRG and comprised surveillance reports, statis-
tical tables (n = 8) and data reported in the text book ‘Dengue en Colombia: epidemiología de la
reemergencia a la hiperendemia (Dengue in Colombia: epidemiology of hyperendemic re-emer-
gence’ [7].
National epidemiology
Between 2000 and 2011, the annual number of non-severe dengue disease cases reported in na-
tionwide surveillance data ranged between 22,775 (2000) and 147,670 (2010) (Fig. 2) [12, 23].
Widespread dengue disease epidemics were observed during 2001–2003 and 2010. A signifi-
cant outbreak of dengue disease occurred between 2001 and 2003 (Fig. 2), peaking in 2002,
when approximately 77,000 non-severe cases of dengue disease were reported (372 cases per
100,000 population) [7, 24]. In this outbreak, the annual number of cases of severe dengue dis-
ease peaked in 2001 (approximately 6,600 cases) and 2002 (5,200–5,300 cases) [7, 23]. During
the period 2004–2008, the annual number of cases was within the range 22,201–39,814 (Fig. 2)
[7, 25, 26]. A slight increase in the number of notified cases of non-severe dengue disease was
observed in 2009 [7] (44,412 [26]; 41,819 [27]).
A record number of cases of non-severe dengue disease was reported for 2010 (range:
147,423 [7, 27]–147,670 [22]). The estimated incidence was 577 per 100,000 population) [7,
28] (Fig. 2). Fewer than half of the cases were confirmed using serological or virological tests.
Following the 2010 epidemic, the reported number of DF and severe dengue disease cases de-
clined dramatically, resulting in a total of 31,372 DF cases in 2011.
Severe disease. Across the period 2000–2010, the annual number of severe dengue disease
cases reached a maximum of 9,777 (38.3 per 100,000 population) in 2010, and a minimum of
1,383 in 2011 (Fig. 2) [7, 23, 29, 30]. The percentage of dengue disease cases classified as severe
(DHF/DSS) changed over time. The percentage of severe cases was lowest in 2011 (4.2%) and
highest in 2005 (16.4%) [7, 29]. There was an apparent increase in the proportion of severe
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cases between 2000 and 2009, whereas the data for 2010 and 2011 suggest a recent decrease[7].
The hospitalization rate for DF cases was 32%, whereas that for severe dengue disease cases
was 79% [30], which were not dissimilar to the rates reported for 2009 (31% and 76%, respec-
tively) [26].
Dengue-related deaths. Compared with data for the 1990s, there was an increase in the
number of dengue-related deaths during 2000–2011. A total of 1,040 dengue-related deaths
were reported during 2000–2011[7], compared with 439 during 1990–1999 [7]. A total of 217
dengue-related deaths were reported during 2010 [7], which was a considerable increase over
the numbers reported in previous years (20–48 annual deaths for 2006–2009). The case fatality
rate among patients with severe dengue disease was generally lower during the review period
(0.1–5.3% during 2000–2010 compared with 0.4–40% during 1990–1999) [7]. However, the
dengue-related case fatality rate (dengue virus infection confirmed by laboratory analysis) in
Fig 1. Results of literature search and evaluation of identified studies according to PRISMA. The
searches identified 225 relevant citations, 28 of which were dengue-related sources fulfilling the inclusion
criteria. All references identified in the on-line database searches were assigned a unique identification
number. Following the removal of duplicates and articles that did not satisfy the inclusion criteria from review
of the titles and abstracts, the full papers of the first selection of references were retrieved either electronically
or in paper form. A further selection was made based on review of the full text of the articles. ASTMH,
American Society of Tropical Medicine and Hygiene; EMBASE, Excerpta Medica Database; LILACS, Latin
American and Caribbean Health Sciences Database; LRG, Literature Review Group; PAHO, Pan American
Health Organization; PRISMA, preferred reporting items of systematic literature reviews and meta-analyses;
SciELO, Scientific Electronic Library Online (*includes access to LILACS and PAHO databases); VHL,
Virtual Health Library. Other† includes unique references identified from other reference sources detailed in
the protocol and LRG bibliographies.
doi:10.1371/journal.pntd.0003499.g001
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2010 (2.2%) was the highest since 2002 [7], and increased to 3.1% in 2011 and 3.9% in 2012
(until 23 July) [31, 32].
Regional epidemiology
Data from the official national reports (Instituto Nacional de Salud) characterize regional vari-
ability in the patterns of dengue disease transmission, which differed between regions and even
between the departments making up the regions (Table 1).
Most cases of dengue disease occurred in the urban areas of Colombia. Approximately half
of all dengue disease cases during the review period were from 18 endemic municipalities.
There was an apparent increase during the review period in the geographical area from which
dengue disease cases were reported in nationwide surveillance data, with a 90% increase in the
number of municipalities between 2000 and 2010 (from 424 to 743) [7]. The incidence of den-
gue disease was generally low in south and south-east Colombia, attributable to this region of
the country having the lowest population density.
The most affected region was Centro Oriente (40% of cases reported during the review peri-
od), mainly concentrated in the departments of Santander, Norte de Santander and Huila. Cen-
tro Occidente was the second most affected region (20%); for the majority of the review period,
most cases in Centro Occidente were in the departments of Quindio and Risaralda, although in
Fig 2. Cases of (A) dengue fever and (B) severe dengue fever in Colombia, 2000–2011 [7]. The
epidemiology of dengue disease in Colombia was characterized by fluctuations in the number of DF cases
(there was a slight baseline increase over time) with major outbreaks in 2001–2003 and 2010. Widespread
dengue disease epidemics were observed during 2001–2003 and 2010. A significant outbreak of dengue
disease occurred between 2001 and 2003. The annual number of severe dengue disease was highest in
2010, and lowest in 2011.
doi:10.1371/journal.pntd.0003499.g002
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2010, the proportion was largest in the department of Antioquia. Costa Atlantica reported 15%
of the cases during the review period, most of which occurred in the departments of Atlantico
and Cesar and Barranquilla district. Costa Pacífica region reported 13% of the total cases; Valle
del Cauca was the principal department in which dengue disease cases occurred (mainly in
2009 and 2010) [7]. Two regional departments, Vaupés and Amazonas (both in the Amazonía
Region), had no dengue disease transmission (despite the presence of the primary vector) until
2009, however, there were reports of dengue disease in both departments during the 2010 out-
break [7].
Demographic patterns of dengue disease in Colombia
Age distribution. From 2000 to 2003, the age distribution of dengue disease was similar to
that noted throughout the 1990s, with the highest incidence in individuals 15–44 years of age
[12]. However, from 2004 to 2010, the age distribution of the disease changed, and the highest
reported incidence was in the<4 years and 5–14 years age groups (Fig. 3) [12, 33].
Regional demographic patterns of dengue disease did not follow precisely the patterns ob-
served at a national level. In a descriptive study, Rodríguez et al. reported data for Palmira
(Valle del Cauca) for 2003, showing that the highest incidences of DF (1,163 per 100,000 popu-
lation) and DHF (27 per 100,000 population) were in individuals 5–14 years of age [33]. The
following year (2004), the highest incidence of DF was reported in individuals aged60 years
(528 per 100,000 population), followed by children<5 years of age (<1 year: 399 per 100,000
Table 1. Number of reported cases of dengue disease and severe dengue disease by region, 2000–2010.
Year Costa Atlántica Centro Oriente Centro Occidente Orinoquía Amazonía Costa Pacífica
Dengue Severe
Dengue
Dengue Severe
Dengue
Dengue Severe
Dengue
Dengue Severe
Dengue
Dengue Severe
Dengue
Dengue Severe
Dengue
2000 5116 342 7453 788 3133 111 1963 143 1409 192 2780 59
2001 7458 3008 26,110 7889 5871 604 2951 483 1254 350 8599 625
2002 15,332 486 24,997 1988 15,563 490 4927 67 1375 103 12,140 1768
2003 4979 145 20,732 3465 14,347 213 5493 80 835 35 5010 917
2004 1848 87 9099 1663 4880 92 3110 64 653 82 1826 238
2005 5522 378 11,014 2945 8671 120 7418 181 587 110 4045 503
2006 7110 607 11,293 3752 5996 164 5372 140 773 179 2095 235
2007 8010 593 12,038 2535 7165 82 6494 533 933 234 3219 567
2008 9632 483 11,471 3096 3808 209 6465 440 839 113 2108 348
2009 5995 293 15,616 4272 2969 122 7250 515 772 82 10,014 1189
2010 12,627 622 49,059 5414 48,561 850 11,349 685 2519 173 20,822 1718
Total 83,629 7044 198,882 37,807 120,964 3057 62,792 3331 11,949 1653 72,658 8167
Total dengue
cases
90,673 236,689 124,021 66,123 13,602 80,825
Mean incidence
(per 100,000
population)
128 119 517 357 197 122 598 607 362 273 173 109
Predominant
DENV serotypes
3 (followed by 1, 2
and 4)
1 and 3 3 (followed by 1, 4
and 2)
1 (followed by 3
and 2)
1 and 2 3 (2001−2002); 2
(2003−2010)
Age groups most
affected
<15 years <15 years 1–14 years 5−14 years (2008:
<1 year)
5–14 years and <1
year
5−14 years (2010:
<4 years)
(Outbreak years, characterized by higher than usual numbers of cases in bold) [7].
doi:10.1371/journal.pntd.0003499.t001
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population 100,000; 1–4 years: 341 per 100,000 population), with no cases of DHF reported for
these age groups. In contrast, in a virological and serological surveillance study supported by
histopathological examination in Guaviare, analysis of sera from 1,049 patients presenting with
fever during the first 37 epidemiological weeks of 2004 showed that the highest frequency of
dengue disease cases was in the 20–29 year age group [34].
Since 2003, there has been a significant increase in deaths in individuals aged<14 years and
>45 years, suggesting a change in the transmission pattern from endemic–epidemic to a hyper-
endemic pattern. The case fatality rate over that period has generally been highest in the group
aged>45 years, except in 2006 when the case fatality rate was highest in the group aged 5–14
years [12].
Sex distribution. Reports from nationwide surveillance data of the distribution of DF and
severe dengue disease by sex in Colombia over the period 2007–2010 have shown that males
and females account for a similar proportion of cases [25, 26, 30]. At a local level, however,
some sex differences have been reported. For example, in a descriptive cross-sectional study of
individuals with symptoms of fever attending a hospital in Puerto Inírida, Guainía, between
November 2007 and February 2008, 1,238 were identified as having probable DF or DHF [35].
Of these patients, 60.8% were female. In contrast, during sentinel surveillance in Guaviare in
2004, 61.6% of confirmed dengue disease cases were in males [34]. In a descriptive, retrospec-
tive study, boys and girls accounted for a similar proportions of children<13 years of age
(n = 105) admitted to hospital in Neiva (Huila) with DF (12.4%) or DHF (87.6%) in 2004 [36].
Dengue virus serotype distribution. For the years when data were available, all DENV se-
rotypes were present in Colombia at some time during the review period (Table 2) [7]. All four
DENV serotypes were co-circulating from 2006 to 2010. DENV-3 re-emerged in 2002 after
Fig 3. Incidence of reported cases of dengue (per 100,000 population) by age group, 2000–2010 [7]. In the early part of the review period, the highest
incidence of dengue disease was in in individuals aged 15–44 years [12]. However, the age distribution of the disease changed and from 2004 to 2010 the
highest reported incidence was in the<4-year-old and 5–14-year-old age groups.
doi:10.1371/journal.pntd.0003499.g003
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being absent for more than two decades; this serotype was then present every year except 2004.
It has been suggested that DENV-3 entered Colombia from Venezuela, with Cucuta as the en-
trance point [17]. A study evaluating the dynamics of transmission of dengue virus during and
after epidemics was conducted between November 2002 and March 2004, and reported the en-
demic circulation of DENV-3 in south-western Colombia after its re-emergence in the north-
western region of the country [37]. Four years after its reappearance in Colombia, DENV-3
Table 2. Serotype distribution in Colombia: national and regional data from 2000 to 2010.
Year Region DENV-
1
DENV-
2
DENV-
3
DENV-
4
Source of data: First author,
year [Ref]
2000* Regional Santander 10% 70% 0% 20% Ocazionez, 2007 [38]
2000/
01
Santander 48.5% Ocazionez, 2007 [38]
2001 National Yes Yes No Yes Padilla, 2012 [7]
Regional Santander 4% 40% 36% 20% Ocazionez, 2007 [38]
Santander 4% 40% 36% 20% Ocazionez, 2007 [38]
2002 National Yes No Yes Yes Padilla, 2012 [7]
Regional Santander 6.7% 6.7% 86.6% 0% Ocazionez, 2007 [38]
Caquetá 2† 0† 0† 0† Mera, 2003 [24]
Guaviare 8† 5† 0† 1† Mera, 2003 [24]
Norte de Santander 0† 0† 0† 1† Mera, 2003 [24]
Putumayo 5† 1† 0† 0† Mera, 2003 [24]
2002/
03
Regional Santander 1.9% 3.8% 94.5% Ocazionez, 2006 [36]
1.1.1.1.1.1.1 Valle del Cauca: cities of Cali, Palmira,
Tuluá and Buenaventura
18.1% 45.2% 7.8% 28.9% Méndez, 2006 [37]
2003 National Yes Yes Yes No Padilla, 2012 [7]
Regional Santander 0% 2.7% 97.3% 0% Ocazionez, 2007 [38]
2003/
04
Regional Santander 88.1% Ocazionez, 2006 [48]
2004 National Yes Yes No Yes Padilla, 2012 [7]
Regional Santander 4.7% 9.5% 75% 14.2% Ocazionez, 2006 [48]
Santander 4.8% 9.5% 71.4% 14.3% Ocazionez, 2007 [38]
2005 National Yes Yes Yes No Padilla, 2012 [7]
Regional Ocaña, Santander 5% 77.5% 12.5% Rangel, 2008 [49]
2006 National Yes Yes Yes Yes Padilla, 2012 [7]
Regional Ocaña, Santander 57.5% 22.5% 27.5% Rangel, 2008 [49]
2007 National Yes Yes Yes Padilla, 2012 [7]
Regional Santander 36.3% 21.2% 42.2% Rangel, 2008 [49]
2007/
08
Regional Puerto Inirida, Guainia 50% 50% Rojas-Álvarez, 2008 [35]
2008 National Yes Yes Yes Yes Padilla, 2012 [7]
Regional Santander 85% 10% 5% Rangel, 2008 [49]
2009* National Yes Yes Yes Yes Padilla, 2012 [7]
2010* National Yes Yes Yes Yes Padilla, 2012 [7]
National data source: Virology Laboratory, National Institute of Health.
DENV, dengue virus.
*National data unavailable for 2000; regional data unavailable for 2009 and 2010.
†Number of positive cases.
doi:10.1371/journal.pntd.0003499.t002
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was detected in the northern, southern and south-eastern regions of Colombia [36]. The reap-
pearance of DENV-3 coincided with a national epidemic, although the lack of a major increase
in the proportion of severe cases suggested no particular association of DENV-3 with severe
disease. During the epidemic of 2009–2010, viral isolation and reverse transcriptase-polymer-
ase chain reaction studies were performed on 662 samples at the Instituto Nacional de Salud
laboratories [7]. DENV-1 (43.8%) and DENV-2 (40.4%) were the predominant serotypes, fol-
lowed by DENV-3 (12.5%) and DENV-4 (3.1%).
Some of the most comprehensive virological and serological regional data for the review pe-
riod were available for the department of Santander (Table 2) [36, 38, 39], with some data avail-
able for other regions. The data from Santander show that changes in relative DENV serotype
abundance during this period have been associated with changes in infection pattern and DHF
frequency [36, 38]. Dengue disease incidence and serotype data were also reported in the de-
partment of Antioquia [40, 41]. The reappearance of DENV-3 appears to have had no impact
on the proportion of dengue disease cases classed as severe in Colombia, indicating that this se-
rotype has no significant effect on disease severity [40].
Phylogenetic studies have demonstrated genetic diversity within viruses of the same geno-
type of DENV-1, DENV-2 and DENV-3. No relationship has been found between DENV vari-
ant and clinical disease severity [10, 17, 40]. Regarding genotypes, for DENV-1, the most
frequent is the genotype V linage 1 and 2; for DENV-2, currently the American–Asiatic geno-
type is circulating; for DENV-3, the genotypes III and recently I are the most common; and for
DENV-4, the genotype circulating in Colombia corresponds to strains from Indonesia, Tahiti,
the Caribbean, and Central and South America [7].
Discussion
This systematic literature review is one of a series conducted within a similar timeframe in se-
lected countries of the Americas and Asia. The series serves to provide an overview of the
changeable epidemiology of DF and severe dengue disease across a broad geographical area
over a decade or more.
This review highlights the record number of cases of non-severe dengue disease reported for
2010 in Colombia. There are many complex factors that may contribute to a high incidence of
dengue infection. The large majority of dengue disease notifications came from urban areas.
High population density and poor infrastructure (e.g., water supplies, sewage systems) encour-
age standing water, thus providing Ae. aegypti breeding sites and facilitating the spread of den-
gue disease in urban areas [42]. Hyperendemicity (the co-circulation of multiple dengue virus
serotypes) [43], high temperatures as a result of the El Niño-Southern Oscillation, combined
with heavy rains [44], as well as the inadequacies of current methods to reduce dengue trans-
mission [45] also contribute to an increase in incidence of disease owing to an increased fre-
quency of epidemic transmission. Socio-economic factors, including income, may also
contribute to high dengue disease endemicity [46]. The recent decrease (2010 and 2011) in the
proportion of severe cases could be explained in part by the change in case definitions of den-
gue disease used in Colombia from January 2010, when the newWHO definitions were
adopted in line with global recommendations [7]. Local variations in the distribution of dengue
disease between males and females could be due to cultural and social differences or underre-
ported cases [47]. The apparent reduction in the case fatality rate between 2000–2010 may re-
flect improvements in diagnosis and treatment, however, the reasons for the more recent
(2010–2011) increase in case fatality rate are unclear.
Changes in the relative abundance of DENV serotype or genotype may potentially affect
dengue virus infection patterns and the frequency of severe disease. For example, although the
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appearance of DENV-3 was closely associated with the epidemic that lasted from 2001 to 2003,
Ospina et al. found that DENV-3 appeared to have no particular association with severe den-
gue disease [40]. Indeed, there is little robust evidence available to show the impact of DENV
serotypes or subtypes on the incidence or severity of dengue disease in Colombia [40].
Some information was either sparse or absent from the selected papers. In particular, there
is a lack of information regarding rates of asymptomatic dengue virus infection, primary and
secondary dengue virus infections, risk factors for severity and under-reporting of dengue dis-
ease in Colombia. These gaps may be addressed by improved surveillance methods for dengue
disease. Other data gaps include national and regional data on seroprevalence (laboratory-con-
firmed cases), the dynamics of dengue disease transmission, and percentages of individuals
with dengue virus infection requiring admission to hospital. No studies assessing the sensitivity
of the epidemiological surveillance system were identified. In particular, accurate seropreva-
lence data will improve knowledge regarding the level of transmission and allow more accurate
estimations of the transmission rate. No comprehensive data on genotype distribution or
change over time were retrieved by this review, and there is a lack of definitive evidence to
characterize the links between DENV serotype, genotype or subtype with the incidence or se-
verity of dengue disease in Colombia. Thus, the reasons behind recent epidemics in Colombia
are poorly understood. Furthermore, as ethnicity is considered to be a factor that may affect
the expression of dengue disease and the risk for severe dengue, more studies on its impact
would be beneficial.
The review protocol aimed to minimize potential exclusions of valuable data sources, a fac-
tor that is a strength of this systematic review. We not only searched for published articles, but
also for relevant books, congress abstracts, theses and dissertations, and unpublished data.
However, this systematic literature review is subject to publication bias and the data presented
in this report should be interpreted accordingly. A further limitation of this review is that none
of the published articles was a population study providing national prevalence data, and conse-
quently it relies heavily on data reported to SIVIGILA. In the years since 2000, national reports
of the annual number of cases of dengue disease have been variable in quality, although regular,
detailed annual reports over the past 3 years (2009–2011) from the Instituto Nacional de Salud
suggest greater vigilance in reporting the disease. The annual reports that have been retrieved
show large variations in the number of notified cases for different years.
Shortcomings of the surveillance system have been highlighted, mainly in relation to it
being a passive system reliant on notification of clinically apparent disease in humans [37]. As
a result, these data may be an under-estimation of the number of cases of dengue disease. The
use of other information systems in some studies (e.g., SIS [susceptible-infected-susceptible]
model, alert action system) introduces the possibility that not all retrieved data are directly
comparable. Clinical symptoms of dengue disease are non-specific and access to dengue diag-
nostic tests is limited in some parts of the country and, therefore, many cases may go undetect-
ed. A correlation has been observed between younger age at presentation of symptoms and a
greater need for hospitalization [23].
Despite the availability of the WHO criteria, consistent interpretation of the clinical criteria
for dengue disease cannot be guaranteed within surveillance programmes, and classification of
cases as severe or non-severe is also liable to vary between physicians. Due to the current pas-
sive system of surveillance of dengue disease cases and challenges in diagnosis, official reports
of epidemiological data are likely to underestimate the disease burden, and over-estimation is
also possible. To improve evaluation of trends in dengue-related morbidity and case fatality, it
would be necessary to assess and optimize the sensitivity and specificity of the surveillance sys-
tem, as well as the classification of severe and lethal cases.
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As noted, extensive serological surveys of the seroprevalence of antibodies to dengue virus
would be needed to provide a more accurate estimate of the disease burden. However, despite
the drawbacks, surveillance data are extremely important for the identification of disease
trends, and the available data do indicate trends in the changing nature of dengue disease in
Colombia over the review period.
Conclusions
Dengue disease is a serious public health priority in Colombia and control of the disease has
been difficult. The period from 2000 to 2011 has been characterized by a stable ‘baseline’ annu-
al number of DF cases, punctuated by major outbreaks in 2001–2003 and 2010. Between 2000
and 2010, there was a general increase in the annual number of DHF cases, but this was fol-
lowed by a considerable decrease in 2011. Conversely, the case fatality rate, which was generally
lower during 2000–2009 than in the 1990s, began to increase in 2010 and showed a large in-
crease in 2011. The geographical spread of dengue disease cases showed a steady increase be-
tween 2000 and 2010, with most of the country affected by the 2010 outbreak. During the
review period, the majority of dengue disease cases in Colombia occurred among those<15
years of age, with the highest incidence in 2009 among infants<1 year of age. Overall, there is
a lack of definitive evidence to characterize the links between DENV serotype, genotype or sub-
type with the incidence or severity of dengue disease in Colombia.
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